These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1105 related articles for article (PubMed ID: 26618460)

  • 1. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes.
    Carruthers J; Carruthers A; Monheit GD; Davis PG
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective and Safe Repeated Full-Face Treatments With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin Boosting Hyaluronic Acid.
    Hedén P; Hexsel D; Cartier H; Bergentz P; Delmar H; Camozzato F; Siega C; Skoglund C; Edwartz C; Norberg M; Kestemont P
    J Drugs Dermatol; 2019 Jul; 18(7):682-689. PubMed ID: 31334927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated Full-Face Aesthetic Combination Treatment With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin-Boosting Hyaluronic Acid After Monotherapy With AbobotulinumtoxinA or Hyaluronic Acid Filler.
    Cartier H; Hedén P; Delmar H; Bergentz P; Skoglund C; Edwartz C; Norberg M; Kestemont P
    Dermatol Surg; 2020 Apr; 46(4):475-482. PubMed ID: 31592825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European observational study.
    Molina B; Grangier Y; Mole B; Ribe N; Martín Diaz L; Prager W; Paliargues F; Kerrouche N
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1382-8. PubMed ID: 25495499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of tear troughs and periorbital lines with a range of customized hyaluronic acid fillers.
    Rzany B; Cartier H; Kestermont P; Trevidic P; Sattler G; Kerrouche N; Dhuin JC
    J Drugs Dermatol; 2012 Jan; 11(1 Suppl):s27-34. PubMed ID: 22497041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical skin therapies in subjects undergoing full facial rejuvenation.
    Dayan SH; Bacos JT; Ho TT; Gandhi ND; Gutierrez-Borst S; Kalbag A
    J Cosmet Dermatol; 2019 Jun; 18(3):798-805. PubMed ID: 31033162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioral rejuvenation with a range of customized hyaluronic acid fillers: efficacy and safety over six months with a specific focus on the lips.
    Cartier H; Trevidic P; Rzany B; Sattler G; Kestemont P; Kerrouche N; Dhuin JC
    J Drugs Dermatol; 2012 Jan; 11(1 Suppl):s17-26. PubMed ID: 22497040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
    Beer KR; Julius H; Dunn M; Wilson F
    J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial.
    Dubina M; Tung R; Bolotin D; Mahoney AM; Tayebi B; Sato M; Mulinari-Brenner F; Jones T; West DP; Poon E; Nodzenski M; Alam M
    J Cosmet Dermatol; 2013 Dec; 12(4):261-6. PubMed ID: 24305424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction.
    Sepehr A; Chauhan N; Alexander AJ; Adamson PA
    Aesthetic Plast Surg; 2010 Oct; 34(5):583-6. PubMed ID: 20383497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsurgical periocular rejuvenation: advanced cosmetic uses of neuromodulators and fillers.
    Pao KY; Mancini R
    Curr Opin Ophthalmol; 2014 Sep; 25(5):461-9. PubMed ID: 24926573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained efficacy and high patient satisfaction after cheek enhancement with a new hyaluronic acid dermal filler.
    Kestemont P; Cartier H; Trevidic P; Rzany B; Sattler G; Kerrouche N; Dhuin JC
    J Drugs Dermatol; 2012 Jan; 11(1 Suppl):s9-16. PubMed ID: 22497039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Patient Satisfaction of a Hyaluronic Acid Filler Producing Enduring Full-Facial Volume Restoration: An 18-Month Open Multicenter Study.
    Talarico S; Meski AP; Buratini L; Manela-Azulay M; Simpson H; Sidou F; Kerrouche N
    Dermatol Surg; 2015 Dec; 41(12):1361-9. PubMed ID: 26606436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments.
    Dayan SH; Ho TT; Bacos JT; Gandhi ND; Kalbag A; Gutierrez-Borst S
    J Drugs Dermatol; 2018 Jan; 17(1):48-54. PubMed ID: 29320587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full-face rejuvenation using a range of hyaluronic acid fillers: efficacy, safety, and patient satisfaction over 6 months.
    Rzany B; Cartier H; Kestemont P; Trevidic P; Sattler G; Kerrouche N; Dhuin JC; Ma YM
    Dermatol Surg; 2012 Jul; 38(7 Pt 2):1153-61. PubMed ID: 22759252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid filler and botulinum Neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy.
    Kenner JR
    J Drugs Dermatol; 2010 Sep; 9(9):1135-8. PubMed ID: 20865847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tear trough rejuvenation: A safety evaluation of the treatment by a semi-cross-linked hyaluronic acid filler.
    Berguiga M; Galatoire O
    Orbit; 2017 Feb; 36(1):22-26. PubMed ID: 28121477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Approach to Multimodal Facial Aesthetic Treatment: Injection Techniques and Treatment Characteristics From the HARMONY Study.
    Narurkar VA; Cohen JL; Dayan S; Kaminer MS; Rivkin A; Shamban A; Sykes JM; Teller CF; Weinkle SH; Werschler WP; Drinkwater A; Pucci ML; Gallagher CJ
    Dermatol Surg; 2016 May; 42 Suppl 2():S177-91. PubMed ID: 27128246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.